Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 20 entries
Sorted by: Best Match Show Resources per page
Children and Adolescents' Behavioral Patterns in Response to Escalating COVID-19 Restriction Reveal Sex and Age Differences.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine

Paulsen M, Zychlinsky Scharff A, de Cassan K, Sugianto RI, Blume C, Blume H, Christmann M, Hauß C, Illig T, Jonczyk R, Klopp N, Kopfnagel V, Lichtinghagen R, Lucas H, Luhr A, Mutschler F, Pietschmann T, Pott PC, Prokein J, Schaefer P, Stahl F, Stanislawski N, von der Born J, Schmidt BMW, Heiden S, Stiesch M, Memaran N, Melk A.
PMID: 34972613
J Adolesc Health. 2021 Nov 24; doi: 10.1016/j.jadohealth.2021.11.021. Epub 2021 Nov 24.

PURPOSE: The COVID-19 pandemic affects students in a myriad of different ways. Our prospective, longitudinal study in a cohort of students in Hannover, Germany explores behavioral patterns during escalating COVID-19 restrictions.METHODS: In total, 777 students between the age of...

Cite
Paulsen M, Zychlinsky Scharff A, de Cassan K, et al. Children and Adolescents' Behavioral Patterns in Response to Escalating COVID-19 Restriction Reveal Sex and Age Differences. J Adolesc Health. 2021;doi: 10.1016/j.jadohealth.2021.11.021.
Paulsen, M., Zychlinsky Scharff, A., de Cassan, K., Sugianto, R. I., Blume, C., Blume, H., Christmann, M., Hauß, C., Illig, T., Jonczyk, R., Klopp, N., Kopfnagel, V., Lichtinghagen, R., Lucas, H., Luhr, A., Mutschler, F., Pietschmann, T., Pott, P. C., Prokein, J., Schaefer, P., Stahl, F., Stanislawski, N., von der Born, J., Schmidt, B. M. W., Heiden, S., Stiesch, M., Memaran, N., & Melk, A. (2021). Children and Adolescents' Behavioral Patterns in Response to Escalating COVID-19 Restriction Reveal Sex and Age Differences. The Journal of adolescent health : official publication of the Society for Adolescent Medicine, . https://doi.org/10.1016/j.jadohealth.2021.11.021
Paulsen, Mira, et al. "Children and Adolescents' Behavioral Patterns in Response to Escalating COVID-19 Restriction Reveal Sex and Age Differences." The Journal of adolescent health : official publication of the Society for Adolescent Medicine vol. (2021). doi: https://doi.org/10.1016/j.jadohealth.2021.11.021
Paulsen M, Zychlinsky Scharff A, de Cassan K, Sugianto RI, Blume C, Blume H, Christmann M, Hauß C, Illig T, Jonczyk R, Klopp N, Kopfnagel V, Lichtinghagen R, Lucas H, Luhr A, Mutschler F, Pietschmann T, Pott PC, Prokein J, Schaefer P, Stahl F, Stanislawski N, von der Born J, Schmidt BMW, Heiden S, Stiesch M, Memaran N, Melk A. Children and Adolescents' Behavioral Patterns in Response to Escalating COVID-19 Restriction Reveal Sex and Age Differences. J Adolesc Health. 2021 Nov 24; doi: 10.1016/j.jadohealth.2021.11.021. Epub 2021 Nov 24. PMID: 34972613; PMCID: PMC8610846.
Copy Download .nbib Format: NLM
Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score.

Practical laboratory medicine

Kaiser T, Kinny-Köster B, Gnewuch C, Karailieva D, Kiehntopf M, Kessler A, Ritter-Sket C, Schmidt M, Brand K, Thiery J, Lichtinghagen R.
PMID: 28856226
Pract Lab Med. 2017 Apr 14;8:41-48. doi: 10.1016/j.plabm.2017.04.002. eCollection 2017 Aug.

BACKGROUND & AIM: Patients with end-stage liver disease require valid estimations of mortality for organ allocation and risk stratification. The model of end-stage liver disease (MELD) score is used for this purpose in most countries and incorporates bilirubin, International...

Cite
Kaiser T, Kinny-Köster B, Gnewuch C, et al. Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score. Pract Lab Med. 2017;8:41-48doi: 10.1016/j.plabm.2017.04.002.
Kaiser, T., Kinny-Köster, B., Gnewuch, C., Karailieva, D., Kiehntopf, M., Kessler, A., Ritter-Sket, C., Schmidt, M., Brand, K., Thiery, J., & Lichtinghagen, R. (2017). Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score. Practical laboratory medicine, 841-48. https://doi.org/10.1016/j.plabm.2017.04.002
Kaiser, Thorsten, et al. "Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score." Practical laboratory medicine vol. 8 (2017): 41-48. doi: https://doi.org/10.1016/j.plabm.2017.04.002
Kaiser T, Kinny-Köster B, Gnewuch C, Karailieva D, Kiehntopf M, Kessler A, Ritter-Sket C, Schmidt M, Brand K, Thiery J, Lichtinghagen R. Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score. Pract Lab Med. 2017 Apr 14;8:41-48. doi: 10.1016/j.plabm.2017.04.002. eCollection 2017 Aug. PMID: 28856226; PMCID: PMC5575426.
Copy Download .nbib Format: NLM
Spontaneous resolution of chronic hepatitis C virus infection after antiviral treatment and relapse.

Hepatology research : the official journal of the Japan Society of Hepatology

Potthoff A, Sarhaddar J, Wiegand J, Lichtinghagen R, Sarrazin C, Ciner A, Hadem J, Trautwein C, Manns MP, Wedemeyer H.
PMID: 15652466
Hepatol Res. 2005 Jan;31(1):18-23. doi: 10.1016/j.hepres.2004.11.007. Epub 2005 Jan 08.

Clearance of acute hepatitis C virus (HCV) infection is associated with strong and multi-specific cellular immune responses which are often weak in chronic hepatitis C. We here report a case of spontaneous and sustained resolution of chronic hepatitis C...

Cite
Potthoff A, Sarhaddar J, Wiegand J, et al. Spontaneous resolution of chronic hepatitis C virus infection after antiviral treatment and relapse. Hepatol Res. 2005;31(1):18-23doi: 10.1016/j.hepres.2004.11.007.
Potthoff, A., Sarhaddar, J., Wiegand, J., Lichtinghagen, R., Sarrazin, C., Ciner, A., Hadem, J., Trautwein, C., Manns, M. P., & Wedemeyer, H. (2005). Spontaneous resolution of chronic hepatitis C virus infection after antiviral treatment and relapse. Hepatology research : the official journal of the Japan Society of Hepatology, 31(1), 18-23. https://doi.org/10.1016/j.hepres.2004.11.007
Potthoff, Andrej, et al. "Spontaneous resolution of chronic hepatitis C virus infection after antiviral treatment and relapse." Hepatology research : the official journal of the Japan Society of Hepatology vol. 31,1 (2005): 18-23. doi: https://doi.org/10.1016/j.hepres.2004.11.007
Potthoff A, Sarhaddar J, Wiegand J, Lichtinghagen R, Sarrazin C, Ciner A, Hadem J, Trautwein C, Manns MP, Wedemeyer H. Spontaneous resolution of chronic hepatitis C virus infection after antiviral treatment and relapse. Hepatol Res. 2005 Jan;31(1):18-23. doi: 10.1016/j.hepres.2004.11.007. Epub 2005 Jan 08. PMID: 15652466.
Copy Download .nbib Format: NLM
N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatment.

Annals of general psychiatry

Kropp S, Tountopoulou A, Schneider U, Lichtinghagen R.
PMID: 15882448
Ann Gen Psychiatry. 2005 May 09;4(1):10. doi: 10.1186/1744-859X-4-10.

BACKGROUND: The potential cardiotoxicity of antipsychotic drugs is well known. The N-terminal fragment of B-type natriuretic peptide (NT-proBNP) is considered to be a possible biomarker in clinical practice for the diagnosis and prognosis in patients with suspected heart failure....

Cite
Kropp S, Tountopoulou A, Schneider U, et al. N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatment. Ann Gen Psychiatry. 2005;4(1):10doi: 10.1186/1744-859X-4-10.
Kropp, S., Tountopoulou, A., Schneider, U., & Lichtinghagen, R. (2005). N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatment. Annals of general psychiatry, 4(1), 10. https://doi.org/10.1186/1744-859X-4-10
Kropp, Stefan, et al. "N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatment." Annals of general psychiatry vol. 4,1 (2005): 10. doi: https://doi.org/10.1186/1744-859X-4-10
Kropp S, Tountopoulou A, Schneider U, Lichtinghagen R. N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatment. Ann Gen Psychiatry. 2005 May 09;4(1):10. doi: 10.1186/1744-859X-4-10. PMID: 15882448; PMCID: PMC1131886.
Copy Download .nbib Format: NLM
High-resolution pediatric reference intervals for 15 biochemical analytes described using fractional polynomials.

Clinical chemistry and laboratory medicine

Zierk J, Baum H, Bertram A, Boeker M, Buchwald A, Cario H, Christoph J, Frühwald MC, Groß HJ, Groening A, Gscheidmeier T, Hoff T, Hoffmann R, Klauke R, Krebs A, Lichtinghagen R, Mühlenbrock-Lenter S, Neumann M, Nöllke P, Niemeyer CM, Ruf HG, Steigerwald U, Streichert T, Torge A, Yoshimi-Nöllke A, Prokosch HU, Metzler M, Rauh M.
PMID: 33565284
Clin Chem Lab Med. 2021 Feb 10;59(7):1267-1278. doi: 10.1515/cclm-2020-1371. Print 2021 Jun 25.

OBJECTIVES: Assessment of children's laboratory test results requires consideration of the extensive changes that occur during physiological development and result in pronounced sex- and age-specific dynamics in many biochemical analytes. Pediatric reference intervals have to account for these dynamics,...

Cite
Zierk J, Baum H, Bertram A, et al. High-resolution pediatric reference intervals for 15 biochemical analytes described using fractional polynomials. Clin Chem Lab Med. 2021;59(7):1267-1278doi: 10.1515/cclm-2020-1371.
Zierk, J., Baum, H., Bertram, A., Boeker, M., Buchwald, A., Cario, H., Christoph, J., Frühwald, M. C., Groß, H. J., Groening, A., Gscheidmeier, T., Hoff, T., Hoffmann, R., Klauke, R., Krebs, A., Lichtinghagen, R., Mühlenbrock-Lenter, S., Neumann, M., Nöllke, P., Niemeyer, C. M., Ruf, H. G., Steigerwald, U., Streichert, T., Torge, A., Yoshimi-Nöllke, A., Prokosch, H. U., Metzler, M., & Rauh, M. (2021). High-resolution pediatric reference intervals for 15 biochemical analytes described using fractional polynomials. Clinical chemistry and laboratory medicine, 59(7), 1267-1278. https://doi.org/10.1515/cclm-2020-1371
Zierk, Jakob, et al. "High-resolution pediatric reference intervals for 15 biochemical analytes described using fractional polynomials." Clinical chemistry and laboratory medicine vol. 59,7 (2021): 1267-1278. doi: https://doi.org/10.1515/cclm-2020-1371
Zierk J, Baum H, Bertram A, Boeker M, Buchwald A, Cario H, Christoph J, Frühwald MC, Groß HJ, Groening A, Gscheidmeier T, Hoff T, Hoffmann R, Klauke R, Krebs A, Lichtinghagen R, Mühlenbrock-Lenter S, Neumann M, Nöllke P, Niemeyer CM, Ruf HG, Steigerwald U, Streichert T, Torge A, Yoshimi-Nöllke A, Prokosch HU, Metzler M, Rauh M. High-resolution pediatric reference intervals for 15 biochemical analytes described using fractional polynomials. Clin Chem Lab Med. 2021 Feb 10;59(7):1267-1278. doi: 10.1515/cclm-2020-1371. Print 2021 Jun 25. PMID: 33565284.
Copy Download .nbib Format: NLM
Angiopoietin-like protein 4 and cardiovascular function in COPD.

BMJ open respiratory research

Waschki B, Kirsten AM, Holz O, Meyer T, Lichtinghagen R, Rabe KF, Magnussen H, Welte T, Watz H, Janciauskiene S.
PMID: 27933182
BMJ Open Respir Res. 2016 Oct 31;3(1):e000161. doi: 10.1136/bmjresp-2016-000161. eCollection 2016.

INTRODUCTION: The coexistence of chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) is frequent and might be inter-related through inflammation-related processes reflected by specific markers. Here, we studied angiopoietin-like protein 4 (ANGPTL4), an upcoming cardiovascular marker, in stable...

Cite
Waschki B, Kirsten AM, Holz O, et al. Angiopoietin-like protein 4 and cardiovascular function in COPD. BMJ Open Respir Res. 2016;3(1):e000161doi: 10.1136/bmjresp-2016-000161.
Waschki, B., Kirsten, A. M., Holz, O., Meyer, T., Lichtinghagen, R., Rabe, K. F., Magnussen, H., Welte, T., Watz, H., & Janciauskiene, S. (2016). Angiopoietin-like protein 4 and cardiovascular function in COPD. BMJ open respiratory research, 3(1), e000161. https://doi.org/10.1136/bmjresp-2016-000161
Waschki, B, et al. "Angiopoietin-like protein 4 and cardiovascular function in COPD." BMJ open respiratory research vol. 3,1 (2016): e000161. doi: https://doi.org/10.1136/bmjresp-2016-000161
Waschki B, Kirsten AM, Holz O, Meyer T, Lichtinghagen R, Rabe KF, Magnussen H, Welte T, Watz H, Janciauskiene S. Angiopoietin-like protein 4 and cardiovascular function in COPD. BMJ Open Respir Res. 2016 Oct 31;3(1):e000161. doi: 10.1136/bmjresp-2016-000161. eCollection 2016. PMID: 27933182; PMCID: PMC5133419.
Copy Download .nbib Format: NLM
Promoter Methylation of LEP and LEPR before and after Bariatric Surgery: A Cross-Sectional Study.

Obesity facts

Wilhelm J, Birkenstock A, Buchholz V, Müller A, Aly SA, Gruner-Labitzke K, Koehler H, Lichtinghagen R, Jahn K, Groh A, Kahl KG, de Zwaan M, Hillemacher T, Bleich S, Frieling H.
PMID: 33530087
Obes Facts. 2021 Feb 02;1-7. doi: 10.1159/000511918. Epub 2021 Feb 02.

INTRODUCTION: DNA methylation constitutes one important epigenetic mechanism that regulates gene expression in human cells. With regard to obesity, bariatric surgery-induced weight loss has been associated with promoter methylation changes in several genes. Hyperleptinemia is a characteristic feature of...

Cite
Wilhelm J, Birkenstock A, Buchholz V, et al. Promoter Methylation of LEP and LEPR before and after Bariatric Surgery: A Cross-Sectional Study. Obes Facts. 2021;1-7doi: 10.1159/000511918.
Wilhelm, J., Birkenstock, A., Buchholz, V., Müller, A., Aly, S. A., Gruner-Labitzke, K., Koehler, H., Lichtinghagen, R., Jahn, K., Groh, A., Kahl, K. G., de Zwaan, M., Hillemacher, T., Bleich, S., & Frieling, H. (2021). Promoter Methylation of LEP and LEPR before and after Bariatric Surgery: A Cross-Sectional Study. Obesity facts, 1-7. https://doi.org/10.1159/000511918
Wilhelm, Julia, et al. "Promoter Methylation of LEP and LEPR before and after Bariatric Surgery: A Cross-Sectional Study." Obesity facts vol. (2021): 1-7. doi: https://doi.org/10.1159/000511918
Wilhelm J, Birkenstock A, Buchholz V, Müller A, Aly SA, Gruner-Labitzke K, Koehler H, Lichtinghagen R, Jahn K, Groh A, Kahl KG, de Zwaan M, Hillemacher T, Bleich S, Frieling H. Promoter Methylation of LEP and LEPR before and after Bariatric Surgery: A Cross-Sectional Study. Obes Facts. 2021 Feb 02;1-7. doi: 10.1159/000511918. Epub 2021 Feb 02. PMID: 33530087; PMCID: PMC7983678.
Copy Download .nbib Format: NLM
Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension.

Frontiers in cardiovascular medicine

Diekmann F, Legchenko E, Chouvarine P, Lichtinghagen R, Bertram H, Happel CM, Hansmann G.
PMID: 34957265
Front Cardiovasc Med. 2021 Dec 08;8:794549. doi: 10.3389/fcvm.2021.794549. eCollection 2021.

No abstract available.

Cite
Diekmann F, Legchenko E, Chouvarine P, et al. Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension. Front Cardiovasc Med. 2021;8:794549doi: 10.3389/fcvm.2021.794549.
Diekmann, F., Legchenko, E., Chouvarine, P., Lichtinghagen, R., Bertram, H., Happel, C. M., & Hansmann, G. (2021). Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension. Frontiers in cardiovascular medicine, 8794549. https://doi.org/10.3389/fcvm.2021.794549
Diekmann, Franziska, et al. "Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension." Frontiers in cardiovascular medicine vol. 8 (2021): 794549. doi: https://doi.org/10.3389/fcvm.2021.794549
Diekmann F, Legchenko E, Chouvarine P, Lichtinghagen R, Bertram H, Happel CM, Hansmann G. Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension. Front Cardiovasc Med. 2021 Dec 08;8:794549. doi: 10.3389/fcvm.2021.794549. eCollection 2021. PMID: 34957265; PMCID: PMC8692707.
Copy Download .nbib Format: NLM
Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension.

Frontiers in cardiovascular medicine

Diekmann F, Legchenko E, Chouvarine P, Lichtinghagen R, Bertram H, Happel CM, Hansmann G.
PMID: 34957265
Front Cardiovasc Med. 2021 Dec 08;8:794549. doi: 10.3389/fcvm.2021.794549. eCollection 2021.

No abstract available.

Cite
Diekmann F, Legchenko E, Chouvarine P, et al. Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension. Front Cardiovasc Med. 2021;8:794549doi: 10.3389/fcvm.2021.794549.
Diekmann, F., Legchenko, E., Chouvarine, P., Lichtinghagen, R., Bertram, H., Happel, C. M., & Hansmann, G. (2021). Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension. Frontiers in cardiovascular medicine, 8794549. https://doi.org/10.3389/fcvm.2021.794549
Diekmann, Franziska, et al. "Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension." Frontiers in cardiovascular medicine vol. 8 (2021): 794549. doi: https://doi.org/10.3389/fcvm.2021.794549
Diekmann F, Legchenko E, Chouvarine P, Lichtinghagen R, Bertram H, Happel CM, Hansmann G. Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension. Front Cardiovasc Med. 2021 Dec 08;8:794549. doi: 10.3389/fcvm.2021.794549. eCollection 2021. PMID: 34957265; PMCID: PMC8692707.
Copy Download .nbib Format: NLM
Do biomarkers allow a differentiation between osteonecrosis of the femoral head and osteoarthritis of the hip? - a biochemical, histological and gene expression analysis.

Osteoarthritis and cartilage

Floerkemeier T, Budde S, Willbold E, Schwarze M, Niehof M, Lichtinghagen R, Windhagen H, Weizbauer A, Reifenrath J.
PMID: 34455078
Osteoarthritis Cartilage. 2021 Nov;29(11):1614-1623. doi: 10.1016/j.joca.2021.08.006. Epub 2021 Aug 26.

OBJECTIVE: Osteonecrosis of the femoral head (ONFH) is a devastating disease of the hip joint. Its early diagnosis is crucial to increase the chances of joint preserving, yet difficult due to similarities with osteoarthritis (OA) of the hip in...

Cite
Floerkemeier T, Budde S, Willbold E, et al. Do biomarkers allow a differentiation between osteonecrosis of the femoral head and osteoarthritis of the hip? - a biochemical, histological and gene expression analysis. Osteoarthritis Cartilage. 2021;29(11):1614-1623doi: 10.1016/j.joca.2021.08.006.
Floerkemeier, T., Budde, S., Willbold, E., Schwarze, M., Niehof, M., Lichtinghagen, R., Windhagen, H., Weizbauer, A., & Reifenrath, J. (2021). Do biomarkers allow a differentiation between osteonecrosis of the femoral head and osteoarthritis of the hip? - a biochemical, histological and gene expression analysis. Osteoarthritis and cartilage, 29(11), 1614-1623. https://doi.org/10.1016/j.joca.2021.08.006
Floerkemeier, T, et al. "Do biomarkers allow a differentiation between osteonecrosis of the femoral head and osteoarthritis of the hip? - a biochemical, histological and gene expression analysis." Osteoarthritis and cartilage vol. 29,11 (2021): 1614-1623. doi: https://doi.org/10.1016/j.joca.2021.08.006
Floerkemeier T, Budde S, Willbold E, Schwarze M, Niehof M, Lichtinghagen R, Windhagen H, Weizbauer A, Reifenrath J. Do biomarkers allow a differentiation between osteonecrosis of the femoral head and osteoarthritis of the hip? - a biochemical, histological and gene expression analysis. Osteoarthritis Cartilage. 2021 Nov;29(11):1614-1623. doi: 10.1016/j.joca.2021.08.006. Epub 2021 Aug 26. PMID: 34455078.
Copy Download .nbib Format: NLM
miR-21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation.

Journal of clinical medicine

Sieweke JT, Pfeffer TJ, Biber S, Chatterjee S, Weissenborn K, Grosse GM, Hagemus J, Derda AA, Berliner D, Lichtinghagen R, Hilfiker-Kleiner D, Bauersachs J, Bär C, Thum T, Bavendiek U.
PMID: 32295105
J Clin Med. 2020 Apr 14;9(4). doi: 10.3390/jcm9041118.

This study aimed to investigate the association of circulating biomarkers with echocardiographic parameters of atrial remodelling and their potential for predicting atrial fibrillation (AF). In patients with and without AF (

Cite
Sieweke JT, Pfeffer TJ, Biber S, et al. miR-21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation. J Clin Med. 2020;9(4)doi: 10.3390/jcm9041118.
Sieweke, J. T., Pfeffer, T. J., Biber, S., Chatterjee, S., Weissenborn, K., Grosse, G. M., Hagemus, J., Derda, A. A., Berliner, D., Lichtinghagen, R., Hilfiker-Kleiner, D., Bauersachs, J., Bär, C., Thum, T., & Bavendiek, U. (2020). miR-21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation. Journal of clinical medicine, 9(4), . https://doi.org/10.3390/jcm9041118
Sieweke, Jan-Thorben, et al. "miR-21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation." Journal of clinical medicine vol. 9,4 (2020). doi: https://doi.org/10.3390/jcm9041118
Sieweke JT, Pfeffer TJ, Biber S, Chatterjee S, Weissenborn K, Grosse GM, Hagemus J, Derda AA, Berliner D, Lichtinghagen R, Hilfiker-Kleiner D, Bauersachs J, Bär C, Thum T, Bavendiek U. miR-21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation. J Clin Med. 2020 Apr 14;9(4). doi: 10.3390/jcm9041118. PMID: 32295105; PMCID: PMC7230176.
Copy Download .nbib Format: NLM
Corrigendum to: A mouse model of cardiogenic shock.

Cardiovascular research

Wang Y, Polten F, Jäckle F, Korf-Klingebiel M, Kempf T, Bauersachs J, Freitag-Wolf S, Lichtinghagen R, Pich A, Wollert KC.
PMID: 34654924
Cardiovasc Res. 2021 Oct 16; doi: 10.1093/cvr/cvab307. Epub 2021 Oct 16.

No abstract available.

Cite
Wang Y, Polten F, Jäckle F, et al. Corrigendum to: A mouse model of cardiogenic shock. Cardiovasc Res. 2021;doi: 10.1093/cvr/cvab307.
Wang, Y., Polten, F., Jäckle, F., Korf-Klingebiel, M., Kempf, T., Bauersachs, J., Freitag-Wolf, S., Lichtinghagen, R., Pich, A., & Wollert, K. C. (2021). Corrigendum to: A mouse model of cardiogenic shock. Cardiovascular research, . https://doi.org/10.1093/cvr/cvab307
Wang, Yong, et al. "Corrigendum to: A mouse model of cardiogenic shock." Cardiovascular research vol. (2021). doi: https://doi.org/10.1093/cvr/cvab307
Wang Y, Polten F, Jäckle F, Korf-Klingebiel M, Kempf T, Bauersachs J, Freitag-Wolf S, Lichtinghagen R, Pich A, Wollert KC. Corrigendum to: A mouse model of cardiogenic shock. Cardiovasc Res. 2021 Oct 16; doi: 10.1093/cvr/cvab307. Epub 2021 Oct 16. PMID: 34654924.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 20 entries